NIH Challenges' Oligonucleotide Toxicity (OligoTox) Open Data Challenge funds open, human cell-based datasets to advance AI-driven prediction of oligonucleotide toxicity.
Alan and Helene Goldberg In Vitro Toxicology Grants support scientists developing toxicology methods to reduce or replace laboratory animals in biomedical research and product safety testing.
Targeting RNA in Disease with Novel Technologies (TRDNT) Challenge – Phase II: Stage I supports teams and organizations developing RNA-targeting prototypes to enable precision therapies for human disease.
Real-World Evidence Innovation Challenge supports individuals, teams, and entities validating clinical data analytic methods to establish reliable, reproducible performance across health systems.
This grant supports early-stage projects to develop innovative experimental and computational tools for comprehensive RNA analysis, aiming to overcome current limitations and advance research on RNA’s roles in health and disease.
This grant supports research to improve how cardiotoxicity from cancer treatments is detected, monitored, and treated, aiming to inform FDA regulatory decisions.